Bracknell, United Kingdom – Boehringer Ingelheim has announced the availability in Great Britain of the first licensed treatment for equine insulin dysregulation, the most common underlying cause of ...
SCOVELLA® is the first therapy specifically developed and approved for the treatment of hyperinsulinemia in insulin-dysregulated horses and ponies1, targeting the key underlying driver of laminitis.² ...
Hosted on MSN
Laminitis in horses: essential guide for every owner
Laminitis is a major health concern, especially in horses and ponies who are overweight. It’s one of the most serious and debilitating conditions affecting the equine population, which can quickly ...
Dr. Andrew van Eps, Associate Professor of Equine Musculoskeletal Research at New Bolton Center, will discuss different approaches for successful prevention and treatment of laminitis, as part of the ...
Joint injections that contain corticosteroids, such as triamcinolone acetonide, are a common anti-inflammatory in an equine veterinarian's toolbox to treat pain and swelling from conditions like ...
A study published in the peer-reviewed Frontiers in Microbiology Journal in September showed promising results for treatment of laminitis with a new drug called methylated tirilazad (product name: PTP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results